278 related articles for article (PubMed ID: 29949147)
1. MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance.
Chen LZ; Ding Z; Zhang Y; He ST; Wang XH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3734-3741. PubMed ID: 29949147
[TBL] [Abstract][Full Text] [Related]
2. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
3. Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.
Zhang JY; Li YN; Mu X; Pan ZL; Liu WB
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8599-8608. PubMed ID: 30575899
[TBL] [Abstract][Full Text] [Related]
4. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells.
Wang JJ; Yu JP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176
[TBL] [Abstract][Full Text] [Related]
5. MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway.
Wang DW; Wang YQ; Shu HS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1241-1248. PubMed ID: 29565480
[TBL] [Abstract][Full Text] [Related]
6. miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1.
Liu Y; Zhang M
Cancer Biother Radiopharm; 2019 Aug; 34(6):398-404. PubMed ID: 30939040
[No Abstract] [Full Text] [Related]
7. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
Han GY; Cui JH; Liang S; Li HL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
[TBL] [Abstract][Full Text] [Related]
8. MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.
Dai H; Wang C; Yu Z; He D; Yu K; Liu Y; Wang S
Cancer Biother Radiopharm; 2018 Apr; 33(3):103-109. PubMed ID: 29641255
[TBL] [Abstract][Full Text] [Related]
9. [Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells].
Zhang Y; Hao T; Zhang H; Wei P; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):247-252. PubMed ID: 29773107
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of miR-124 inhibits invasion and proliferation of prostate cancer cells through mediating JAK-STAT3 signaling pathway.
Wu Z; Huang W; Chen B; Bai PD; Wang XG; Xing JC
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2338-2345. PubMed ID: 28617558
[TBL] [Abstract][Full Text] [Related]
12. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
[TBL] [Abstract][Full Text] [Related]
13. Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells.
Li W; Jiang Y; Wu X; Yang F
Cancer Biother Radiopharm; 2019 Sep; 34(7):480-485. PubMed ID: 31135180
[No Abstract] [Full Text] [Related]
14. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
Huang Y; Zou Y; Lin L; Ma X; Zheng R
Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139
[TBL] [Abstract][Full Text] [Related]
15. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1.
Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3333-3341. PubMed ID: 29917183
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway.
Wang BQ; Yang B; Yang HC; Wang JY; Hu S; Gao YS; Bu XY
Brain Res Bull; 2018 Sep; 142():96-106. PubMed ID: 29908894
[TBL] [Abstract][Full Text] [Related]
17. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
18. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
19. Up-Regulation of MicroRNA-133a Inhibits the MEK/ERK Signaling Pathway to Promote Cell Apoptosis and Enhance Radio-Sensitivity by Targeting EGFR in Esophageal Cancer In Vivo and In Vitro.
Yang QS; Jiang LP; He CY; Tong YN; Liu YY
J Cell Biochem; 2017 Sep; 118(9):2625-2634. PubMed ID: 27933650
[TBL] [Abstract][Full Text] [Related]
20. Re-expression of microRNA-4319 inhibits growth of prostate cancer via Her-2 suppression.
Lin X; Wang Y
Clin Transl Oncol; 2018 Nov; 20(11):1400-1407. PubMed ID: 29633185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
